Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial

Stephan Kadauke, Regina M. Myers, Yimei Li, +18

Journal of Clinical Oncology

Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

Regina M. Myers, Yimei Li, Allison Barz Leahy, +26

Journal of Clinical Oncology

Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.

Angela DeMichele, Anne-Marie Martin, Rosemarie Mick, +7

PubMed

Breast OncologyHigh-risk Breast CancerGenetic EpidemiologyImmunologyPathology +22

CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials

Allison Barz Leahy, Haley Newman, Yimei Li, +13

The Lancet Haematology

Cell TherapyMedicineImmunologyClinical TrialsPost-hoc Analysis +6

Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapy

Allison Barz Leahy, Kaitlin J. Devine, Yimei Li, +13

Blood

Drug-Metabolizing Enzyme Polymorphisms Predict Clinical Outcome in a Node-Positive Breast Cancer Cohort

Angela DeMichele, Richard Aplenc, Jeffrey Botbyl, +9

Journal of Clinical Oncology

Ethnic Disparities in Adjuvant Chemotherapy for Breast Cancer Are Not Caused by Excess Toxicity in Black Patients

Karen L. Smith, Lisa Wray, Melissa Klein-Cabral, +4

Clinical Breast Cancer

Ethnic DisparitiesBreast OncologyOncologyAfrican American StudiesBlack Women +8

Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy

Haley Newman, Yimei Li, Hongyan Liu, +19

Blood

Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia

Regina M. Myers, Kaitlin J. Devine, Yimei Li, +20

Blood Advances

Unrelated donor α/β T cell– and B cell–depleted HSCT for the treatment of pediatric acute leukemia

Allison Barz Leahy, Yimei Li, Julie‐An Talano, +11

Blood Advances

ImmunologyTransplantation MedicineAcute LeukemiaHematological MalignancyChronic Gvhd +16